Cai MC - Search Results

1

Clinicopathological, microenvironmental and genetic determinants of molecular subtypes in KEAP1/NRF2-mutant lung cancer.

Cai MC, Chen M, Ma P, Wu J, Lu H, Zhang S, Liu J, Zhao X, Zhuang G, Yu Z, Fu Y. Cai MC, et al. Int J Cancer. 2019 Feb 15;144(4):788-801. doi: 10.1002/ijc.31975. Epub 2018 Dec 4. Int J Cancer. 2019. PMID: 30411339

2

BET Bromodomain Inhibition as a Therapeutic Strategy in Ovarian Cancer by Downregulating FoxM1.

Zhang Z, Ma P, Jing Y, Yan Y, Cai MC, Zhang M, Zhang S, Peng H, Ji ZL, Di W, Gu Z, Gao WQ, Zhuang G. Zhang Z, et al. Among authors: cai mc. Theranostics. 2016 Jan 1;6(2):219-30. doi: 10.7150/thno.13178. eCollection 2016. Theranostics. 2016. PMID: 26877780 Free PMC article.

3

A VEGF-dependent gene signature enriched in mesenchymal ovarian cancer predicts patient prognosis.

Yin X, Wang X, Shen B, Jing Y, Li Q, Cai MC, Gu Z, Yang Q, Zhang Z, Liu J, Li H, Di W, Zhuang G. Yin X, et al. Among authors: cai mc. Sci Rep. 2016 Aug 8;6:31079. doi: 10.1038/srep31079. Sci Rep. 2016. PMID: 27498762 Free PMC article.

4

Preclinical Efficacy and Molecular Mechanism of Targeting CDK7-Dependent Transcriptional Addiction in Ovarian Cancer.

Zhang Z, Peng H, Wang X, Yin X, Ma P, Jing Y, Cai MC, Liu J, Zhang M, Zhang S, Shi K, Gao WQ, Di W, Zhuang G. Zhang Z, et al. Among authors: cai mc. Mol Cancer Ther. 2017 Sep;16(9):1739-1750. doi: 10.1158/1535-7163.MCT-17-0078. Epub 2017 Jun 1. Mol Cancer Ther. 2017. PMID: 28572168

5

Clonality, Heterogeneity, and Evolution of Synchronous Bilateral Ovarian Cancer.

Yin X, Jing Y, Cai MC, Ma P, Zhang Y, Xu C, Zhang M, Di W, Zhuang G. Yin X, et al. Among authors: cai mc. Cancer Res. 2017 Dec 1;77(23):6551-6561. doi: 10.1158/0008-5472.CAN-17-1461. Epub 2017 Sep 28. Cancer Res. 2017. PMID: 28972072

6

Simultaneous evolutionary expansion and constraint of genomic heterogeneity in multifocal lung cancer.

Ma P, Fu Y, Cai MC, Yan Y, Jing Y, Zhang S, Chen M, Wu J, Shen Y, Zhu L, Chen HZ, Gao WQ, Wang M, Gu Z, Bivona TG, Zhao X, Zhuang G. Ma P, et al. Among authors: cai mc. Nat Commun. 2017 Oct 10;8(1):823. doi: 10.1038/s41467-017-00963-0. Nat Commun. 2017. PMID: 29018192 Free PMC article.

7

Prevalence and clonality of synchronous primary carcinomas in the bladder and prostate.

Jing Y, Zhang R, Ma P, Cai MC, Zhuang G, Chen H. Jing Y, et al. Among authors: cai mc. J Pathol. 2018 Jan;244(1):5-10. doi: 10.1002/path.4997. J Pathol. 2018. PMID: 29023722

8

Comprehensive genomic profiling of neuroendocrine bladder cancer pinpoints molecular origin and potential therapeutics.

Shen P, Jing Y, Zhang R, Cai MC, Ma P, Chen H, Zhuang G. Shen P, et al. Among authors: cai mc. Oncogene. 2018 May;37(22):3039-3044. doi: 10.1038/s41388-018-0192-5. Epub 2018 Mar 14. Oncogene. 2018. PMID: 29535424

9

Molecular Targeted Therapies Elicit Concurrent Apoptotic and GSDME-Dependent Pyroptotic Tumor Cell Death.

Lu H, Zhang S, Wu J, Chen M, Cai MC, Fu Y, Li W, Wang J, Zhao X, Yu Z, Ma P, Zhuang G. Lu H, et al. Among authors: cai mc. Clin Cancer Res. 2018 Dec 1;24(23):6066-6077. doi: 10.1158/1078-0432.CCR-18-1478. Epub 2018 Jul 30. Clin Cancer Res. 2018. PMID: 30061362

10

Hybrid sequencing-based personal full-length transcriptomic analysis implicates proteostatic stress in metastatic ovarian cancer.

Jing Y, Zhang Y, Zhu H, Zhang K, Cai MC, Ma P, Shen P, Zhang Z, Shao M, Wang J, Yu M, Yin X, Zhang M, Hu Y, Chen D, Di W, Wang X, Zhuang G. Jing Y, et al. Among authors: cai mc. Oncogene. 2019 Apr;38(16):3047-3060. doi: 10.1038/s41388-018-0644-y. Epub 2019 Jan 7. Oncogene. 2019. PMID: 30617306

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

68 results

Search Page

Filters